# US 6,730,298 B2 · Tissue formation by injecting a cell-polymeric solution that gels in vivo

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,298 B2
- Document ID: US6730298B2
- Status: Granted
- Kind: B2
- Application number: 09/008,945
- Filed: 1998-01-20
- Published: 2001-12-20
- Granted: 2004-05-04
- Earliest claimed: 1993-04-30
- Assignees: Massachusetts Institute of Technology; Children's Medical Center Corporation
- Inventors: Linda Griffith-Cima; Anthony Atala; Charles A. Vacanti; Keith T. Paige
- Web page: https://patentgrep.com/patent/US6730298B2

## CPC

- A61L 27/383: {Nerve cells, e.g. dendritic cells, Schwann cells}
- A61F 2/0036: {implantable (A61F2/0018 takes precedence)}
- A61F 2/02: Prostheses implantable into the body
- A61K 35/34: Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44)
- A61L 27/20: Polysaccharides
- A61L 27/222: {Gelatin}
- A61L 27/24: Collagen
- A61L 27/3826: {Muscle cells, e.g. smooth muscle cells}
- A61L 27/3839: {characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}
- A61L 27/3847: {Bones}
- A61L 27/3852: {Cartilage, e.g. meniscus}
- A61L 27/3882: {Hollow organs, e.g. bladder, esophagus, urether, uterus}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/52: Hydrogels or hydrocolloids
- C12N 5/0068: {General culture methods using substrates (for specific animal cell type C12N5/06)}
- A61F 2/0059: {Cosmetic or alloplastic implants (A61F2/10 - A61F2/16, A61F2/28 take precedence)}
- A61F 2310/00365: Proteins; Polypeptides; Degradation products thereof
- A61F 2310/00383: Gelatin
- A61L 2400/06: Flowable or injectable implant compositions
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Slowly polymerizing polysaccharide hydrogels have been demonstrated to be useful as a means of delivering large numbers of isolated cells via injection. The gels promote engraftment and provide three dimensional templates for new cell growth. The resulting tissue is similar in composition and histology to naturally occurring tissue. This method can be used for a variety of reconstructive procedures, including custom molding of cell implants to reconstruct three dimensional tissue defects, as well as implantation of tissues generally.

## Claims

### Claim 1

A method for introducing cells into an animal to form tissue, comprising:
forming a cell-polymeric composition by mixing dissociated cells with a solution of a biodegradable, biocompatible natural or synthetic organic polymer;
introducing said cell-polymeric composition into the animal; and
following the step of introducing, hardening the polymer into a three-dimensional open-lattice structure which entraps water molecules to form a hydrogel containing the dissociated cells.

### Claim 2 (depends on 1)

The method of claim 1, wherein the natural or synthetic organic polymer is selected from the group consisting of alginate, polyphosphazines, polyethlene oxide-propylene glycol block copolymers, poly(acrylic acids), poly(methacrylic acids), copolymers of acrylic acid and methacrylic acid, poly(vinyl acetate), and sulfonated polymers.

### Claim 3 (depends on 2)

The method of claim 2, wherein hardening comprises cross-linking the polymer with multivalent ions.

### Claim 4 (depends on 1)

The method of claim 1, wherein hardening comprises exposing the polymer to an agent selected from the group consisting of ions, pH changes, and temperature changes.

### Claim 5 (depends on 4)

The method of claim 4, wherein hardening comprises allowing the polymer to interact with cations selected from the group consisting of copper, calcium, aluminum, magnesium, strontium, barium, tin, and di-, tri- or tetra-functional organic cations: or anions selected from the group consisting of low molecular weight dicarboxylic acids, sulfate ions and carbonate ions.

### Claim 6 (depends on 1)

The method of claim 1, wherein the cells are selected from the group consisting of cells that form cartilage, cells that form bone, muscle cells, fibroblasts, and organ cells.

### Claim 7 (depends on 6)

The method of claim 6, wherein the cells that form cartilage comprise chondrocytes.

### Claim 8 (depends on 6)

The method of claim 6, wherein the cells that form bone comprise osteoblasts.

### Claim 9

A method for introducing cells into an animal to form tissue, comprising:
forming a cell-polymeric composition by mixing dissociated cells with a solution of a biodegradable, biocompatible natural or synthetic organic polymer;
introducing said sell-polymeric composition into the animal; and
hardening the polymer into a three-dimensional open-lattice structure which entraps water molecules to form a hydrogel construct in which the dissociated cells are uniformly distributed,
wherein the step of hardening is completed after introduction of said cell-polymeric composition into the animal.

### Claim 10 (depends on 9)

The method of claim 9, wherein the natural or synthetic organic polymer is selected from the group consisting of alginate, polyphosphazines, polyethlene oxide-propylene glycol block copolymers, poly(acrylic acids), poly(methacrylic acids), copolymers of acrylic acid and methacrylic acid, poly(vinyl acetate), and sulfonated polymers.

### Claim 11 (depends on 9)

The method of claim 9, wherein the step of hardening is initiated to partially harden the polymer before the step of introducing.

### Claim 12 (depends on 9, 11)

The method of claim 9 or 11, wherein hardening comprises cross-linking the polymer with multivalent ions.

### Claim 13 (depends on 9, 11)

The method of claim 9 or 11, wherein hardening comprises exposing the polymer to an agent selected from the group consisting of ions, pH changes, and temperature changes.

### Claim 14 (depends on 13)

The method of claim 13, wherein hardening comprises allowing the polymer to interact with cations selected from the group consisting of copper, calcium, aluminum, magnesium, strontium, barium, tin, and di-, tri- or tetra-functional organic cations: or anions selected from the group consisting of low molecular weight dicarboxylic acids, sulfate ions and carbonate ions.

### Claim 15 (depends on 9)

The method of claim 9, wherein the cells are selected from the group consisting of cells that form cartilage, cells that form bone, muscle cells, fibroblasts, and organ cells.

### Claim 16 (depends on 15)

The method of claim 15, wherein the cells that form cartilage comprise chondrocytes.

### Claim 17 (depends on 15)

The method of claim 15, wherein the cells that form bone comprise osteoblasts.
